Correlation of serum chromium, zinc, magnesium and SOD levels with HbA1c in type 2 diabetes: A cross sectional analysis

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 10, Issue 1, 2016, Pages S126-S129

  Doddigarla, Zephy ^a   Parwez, Iqbal ^b   Ahmad, Jamal ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

^b ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

HbA1c; SOD; T2DM

Indexed keywords

CHROMIUM; HEMOGLOBIN; HEMOGLOBIN A1C; MAGNESIUM; SUPEROXIDE DISMUTASE; ZINC; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN VARIANT;

ADULT; ARTICLE; BODY MASS; CELL DAMAGE; CHROMIUM BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC PATIENT; DISEASE COURSE; GLYCATION; HUMAN; MAGNESIUM BLOOD LEVEL; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; ZINC BLOOD LEVEL; BLOOD; CASE CONTROL STUDY; FEMALE; MALE; METABOLISM; CLINICAL ARTICLE; COMPARATIVE STUDY; CORRELATIONAL STUDY; DIET RESTRICTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TERTIARY CARE CENTER;

CASE-CONTROL STUDIES; CHROMIUM; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MAGNESIUM; MALE; MIDDLE AGED; SUPEROXIDE DISMUTASE; ZINC;

EID: 85015388293     PISSN: 18714021     EISSN: 18780334     Source Type: Journal    
DOI: 10.1016/j.dsx.2015.10.008     Document Type: Article

References (35)

1. Mooradian, A.D., Failla, M., Hoogwerf, B., Marynuik, M., Wylie-Rosett, J., Selected vitamins and minerals in diabetes. Diabetes Care 17 (2009), 464–479.
2. Anderson, R.A., Chromium, glucose intolerance and diabetes. J Am Coll Nutr 17 (2008), 548–555.
3. Kahn, C.R., Current concepts of the molecular mechanism of insulin action. Ann Rev Med 36 (1985), 429–451.
4. Roth, R.A., Lui, F., Chin, J.E., Biochemical mechanisms of insulin resistance. Hormone Res 41:Suppl. 2 (1994), 51–55.
5. Tuman, R.W., Doisy, R.J., Metabolic effects of the glucose tolerance factor (GTF) in normal and genetically diabetic mice. Diabetes 26 (2007), 820–826.
6. Kinlaw, W., Levine, A., Morley, J., Abnormal zinc metabolism in type II diabetes mellitus. Am J Med 75 (1983), 273–277.
7. Niewohner, C., Allen, J., Boosalis, M., Role of zinc supplementation in type II diabetes mellitus. Am J Med 81 (1986), 63–68.
8. Pickup, J.C., Crook, M.A., Is type II diabetes mellitus a disease of the innate immune system?. Diabetologia 41 (1998), 1241–1248.
9. Simmons, D., Joshi, S., Shaw, J., Hypomagnesaemia is associated with diabetes: not pre-diabetes, obesity or the metabolic syndrome. Diabetes Res Clin Pract 87:2 (2010), 261–266.
10. Al-Osali, M.E., Al-Qassabi, S.S., ElSayed, M.K., Hypomagnesemia in type 2 diabetic Omani patients. Saudi Med J 30:7 (2009), 897–901.
11. Villegas, R., Gao, Y.T., Dai, Q., Yang, G., Cai, H., Li, H., Zheng, W., Shu, X.O., Dietary calcium and magnesium intakes and the risk of type 2 diabetes: the Shanghai Women's Health Study. Am J Clin Nutr 89:4 (2009), 1059–1067.
12. Bunn, H., Haney, D., Kamin, S., et al. The biosynthesis of human hemoglobin A1c. Slow glycosylation of hemoglobin in vivo. J Clin Invest 57 (1976), 1652–1659.
13. Goldstein, D.E., Little, R.R., Lorenz, R.A., et al. Tests of glycemia in diabetes. Diabetes Care 27:Suppl. 1 (2004), S91–S93.
14. Rains, J.L., Jain, S.K., Oxidative stress, insulin signalling and Diabetes. Free Radic Biol Med 50:5 (2011), 567–575.
15. Jain, S.K., Hyperglycemia can cause membrane lipid peroxidation and osmoic fragility in human red blood cells. J Biol Chem 264 (1989), 21340–21345.
16. Jain, S.K., McVie, R., Duett, J., Herbst, J., Erythrocyte membrane lipid peroxidation and glycosylated haemoglobin in diabetes. Diabetes 38 (1989), 1539–1543.
17. Fernando, G., Brownlee, M., Oxidative stress and diabetic complications. Circ Res, 107, 2010 1058-0.
18. Brownlee, M., Biochemistry and molecular cell biology of diabetic complications. Nature 414:6865 (2001), 813–820.
19. Urone, P.F., Anders, H.K., Determination of small amounts of chromium in human blood, tissues, and urine. Anal Chem, 22(10), 1950, 1317.
20. Marklund, S., Marklund, G., Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 47:3 (1974), 469–474.
21. Nandi, A., Chatterjee, I.B., Assay of superoxide dismutase activity in animal tissues. J Biosci 13:3 (1988), 305–315.
22. Gavali, Y., Deore, D., Surwase, S., Zingade, U., Study of the serum superoxide dismutase levels in smoking and non-smoking patients with COPD. Int J Recent Trends Sci Technol 5:3 (2011), 121–126.
23. Ghosh, D., Bhattacharya, B., Mukherjee, B., Manna, B., Sinha, M., Chowdhury, J., et al. Role of chromium supplementation in Indians with type 2 diabetes mellitus. J Nutr Biochem 13:11 (2002), 690–697.
24. Ding, W., Chai, Z., Duan, P., Feng, W., Qian, Q., Serum and urine chromium concentrations in elderly diabetics. Biol Trace Element Res 63:3 (1998), 231–237.
25. Zima, T., Mestek, O., Tesar, V., Tesarova, P., Nemecek, K., Zak, A., et al. Chromium levels in patients with internal diseases. IUBMB Life 46:2 (1998), 365–374.
26. Ekmekcioglu, C., Prohaska, C., Pomazal, K., Steffan, I., Schernthaner, G., Marktl, W., Concentrations of seven trace elements in different hematological matrices in patients with type 2 diabetes as compared to healthy controls. Biol Trace Element Res 79:3 (2001), 205–219.
27. Cheng, H.H., Lai, M.H., Hou, W.C., Huang, C.L., Antioxidant effects of chromium supplementation with type 2 diabetes mellitus and euglycemic subjects. J Agric Food Chem 52:5 (2004), 1385–1389.
28. Anderson, R.A., Cheng, N., Bryden, N.A., Polansky, M.M., Cheng, N., Chi, J., et al. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes 46:11 (1997), 1786–1791.
29. Kleefstra, N., Houweling, S.T., Jansman, F.G., Groenier, K.H., Gans, R.O., Meyboom-de Jong, B., et al. Chromium treatment has no effect in patients with poorly controlled. Insulin-treated type 2 diabetes in an obese western population a randomized, double-blind, placebo-controlled trial. Diabetes Care 29:3 (2006), 521–525.
30. Shinde, S.N., Dhadke, V.N., Suryakar, A.N., Evaluation of oxidative stress in type 2 Diabetes mellitus and follow-up along with vitamin E supplementation. Indian J Clin Biochem 26:1 (2011), 74–77.
31. Vuciíc, M., Gavella, M., Bozikov, V., Ashcroft, S.J., Rocic, B., Superoxide dismutase activity in lymphocytes and polymorphonuclear cells of diabetic patients. European J Clin Chem Biochem 35 (1997), 517–521.
32. Kimura, F., Hasegawa, G., Obayashi, H., Adachi, T., Hara, H., Ohta, M., Yoshikawa, T., Serum extracellular superoxide dismutase in patients with type 2 diabetes relationship to the development of micro-and macrovascular complications. Diabetes Care 26:4 (2003), 1246–1250.
33. Turk, H.M., Sevinc, A., Camci, C., Cigli, A., Buyukberber, S., Savli, H., et al. Plasma lipid peroxidation products and antioxidant enzyme activities in patients with type 2 diabetes mellitus. Acta Diabetol 39:3 (2002), 117–122.
34. Ookawara, T., Kawamura, N., Kitagawa, Y., Taniguchi, N., Site-specific and random fragmentation of Cu, Zn-superoxide dismutase by glycation reaction: implication of reactive oxygen species. J Biol Chem 267 (1992), 18505–18510.
35. Hartnett, M.E., Stratton, R.D., Browne, R.W., Rosner, B.A., Lanham, R.J., Armstrong, D.O.N.A.L.D., Serum markers of oxidative stress and severity of diabetic retinopathy. Diabetes Care 23:2 (2000), 234–240.